Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Demand notices of Rs...

    Demand notices of Rs 74.65 crore issued to pharma firms: Govt

    Written by Ruby Khatun Khatun Published On 2017-07-24T14:12:04+05:30  |  Updated On 24 July 2017 2:12 PM IST
    Demand notices of Rs 74.65 crore issued to pharma firms: Govt

    New Delhi: The government said demand notices of Rs 74.65 crore have been issued to pharmaceutical companies which have launched drugs without prior price approval from National Pharmaceuticals Pricing Authority (NPPA).


    During the monitoring of compliance of DPCO 2013 by drug makers, it was seen that the provisions related to new drugs had not been followed in some cases and pharma firms have launched the formulations without taking prior price approval from NPPA, Minister of State for Chemicals & Fertilisers Mansukh L Mandaviya said in reply to a question in the Rajya Sabha.


    The concerned companies were asked to furnish certified batch wise production and sales details along with the corresponding MRP for the formulations from the date of launch of the product till date, he added.



    "Demand notices for an amount of Rs 74.65 crore have been issued to the erring pharmaceutical companies for launching such drugs / medicines without prior price approval of NPPA", Mandaviya said.

    Out of this, an amount of Rs 1.05 crore has so far been recovered, he added.


    The government is effectively monitoring the prices of scheduled medicines and taking action against companies found overcharging the consumers, Mandaviya said.

    demandDemand NoticegovernmentMansukh L MandaviyaNational Pharmaceuticals Pricing AuthorityNoticeNPPApharmaceutical companies
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok